New MAKOplasty Procedure at FGH Offers Treatment Option for Osteoarthritis of the Knee
Osteoarthritis is the most common form of arthritis and a leading cause of disability worldwide, according to the American Academy of Orthopaedic Surgeons. Fortunately, many of those suffering from this painful condition in the Pine Belt can benefit from a treatment option that increases their chances of returning to an active lifestyle.
MAKOplasty® is a Partial Knee Resurfacing procedure designed to relieve the pain caused by osteoarthritis for patients with early to mid-stage osteoarthritis that has not affected their entire knee. MAKOplasty® has been shown to improve surgical results and shorten hospital stays, thanks to the less-invasive surgical procedure that uses smaller incisions, reduces blood loss and leaves less scarring. This new procedure is proven to give patients more natural knee function after surgery, helping them get back to an active lifestyle. In many cases, patients are allowed to walk soon after surgery, drive a car in the first few weeks and return to normal daily activities shortly thereafter. MAKOplasty® is powered by MAKO's robotic arm system, which allows the physician to reproduce the same precision during every patient's procedure.
"Forrest General invested in MAKO robotic technology because we are committed to providing the most advanced treatment options for patients in South Mississippi," said Steve Jackson, orthopedic and neuroscience service line administrator.
"The MAKO system brings a new tool in the treatment of knee pain."
Anyone interested in this procedure should first talk with their doctor to see whether they may be a good candidate. However, typical MAKOplasty® patients share several characteristics, including suffering from knee pain with activity on the inner or outer knee or under the knee cap and start up knee pain or stiffness when activities are initiated from a sitting position. The MAKOplasty® procedure is helpful for those patients whose osteoarthritis has not responded to non-surgical treatments or non-steroidal anti-inflammatory medication.
For more information on this new procedure or for physician referrals or to register for the November 13 seminar, please call FGH OnCall at 1-800-844-4445.
Forrest General receives American Heart Association's Mission: Lifeline Silver Quality Achievement Award recognizing outstanding care of STEMI Heart Attack patients
Forrest General is certified as a Primary Stroke Center by DNV Healthcare, Inc.
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Copyright 2009 - 2011. 6051 US Highway 49, Hattiesburg MS 39401